The University of Chicago Header Logo

Connection

Daniel Arber to Imatinib Mesylate

This is a "connection" page, showing publications Daniel Arber has written about Imatinib Mesylate.
Connection Strength

0.013
  1. Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. Blood. 2003 Jun 15; 101(12):4701-7.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.